Inflammatory markers are considered closely related to obesity, and in our meta-analysis, we found that PBM can significantly reduce CRP levels [MD = − 0.99, 95% CI (− 1.17 to − 0.82), p < 0.00001]. Here, CRP is linked to obesity due to melanocortin 4 receptor deficiency.